Non-invasive Monitoring: Impact on Patient Management and Outcomes

Completed

Conditions studied: No Specific Medical Conditions or Disease States

In brief

Enhancing patient monitoring in SNFs and ALFs is crucial due to challenges in recognizing deteriorating health. Gaps in vital sign checks lead to missed indicators and adverse outcomes. Turtle Shell Technologies' Dozee Pro NX offers continuous non-invasive monitoring, alerting healthcare providers of vital sign changes. This clinical study aims to evaluate Dozee Pro Nx's impact on patient outcomes, practitioner efficiency, and healthcare costs in SNFs and ALFs, addressing gaps in care delivery.

Key facts

Study ID

NCT06270953

Run by

Turtle Shell Technologies Pvt. Ltd.

People needed

54

Starts

2024-01-19

Expected to finish

2024-06-30

Last updated by the study team

2025-09-29

Who can join

Age: 2 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older.
• Weight between 40kg-120kgs

You may not qualify if…

• Terminal illness with a life expectancy of less than 1 month.
• Have any condition that could interfere with the subject's ability to lie flat or stable on the bed
• Needs the use of equipment whose operation can interfere with Investigation System operations
• Patients planned to be transferred from the facility within 72 hours
• Prisoners
• Pregnant

Where it is running

• Oak Village Healthcare — Lake Jackson, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.